Results: 5

Successful multiple-exchange peritoneal dialysis in a patient with severe hematological toxicity by methotrexate: case report and literature review

J. bras. nefrol; 41 (3), 2019
Abstract Methotrexate is an effective medication to control several diseases; however, it can be very toxic, being myelosuppression one of its main adverse effects, which increases in severity and frequency in patients with renal failure. We present the case of a 68-year-old man with chronic, end-stage r...

Prevalence of low folate deficiency after wheat flour supplementation - should we still measure serum folate?

ABSTRACT Objectives: To determine the frequency of folic acid deficiency in consecutive serum folate determinations and to determine whether there was a significant decrease in serum folate deficiency after folate was added to wheat flour. Methods: A retrospective descriptive observational study was pe...

The effect of hippophae rhamnoides extract on oral mucositis induced in rats with methotrexate

J. appl. oral sci; 24 (5), 2016
ABSTRACT Objective: To investigate the effect of HRE (Hippophae rhamnoides extract) on oral mucositis induced in rats with MTX. Material and Methods: Experimental animals were divided into groups as healthy (HG), HRE+MTX (HMTX), and control group, which received MTX (MTXC). HMTX group received 50 mg/kg...

Ulcerations due to methotrexate toxicity in a psoriasis patient

An. bras. dermatol; 91 (3), 2016
Abstract: Methotrexate is one of the most used drugs in the treatment of psoriasis with indication of systemic therapy. Cutaneous and mucous side effects are described by pharmacological characteristics of the drug itself or due to overdose. We report the case of a patient with ulcerations in oral mucosa...

Experiencia clínica con la asociación de trimetoprima-sulfametoxazol en pediatría
[Clinical experience with a trimethoprim-sulfamethoxazole combination in pediatrics]

Arch. argent. pediatr; 69 (4), 1971
Se realizó un ensayo con una nueva asociación trimetoprima/sulfametoxazol a la dosis de 4 a 8 mg de trimetoprima/Kg/día y 20 a 40 mg/sulfametoxazol/Kg/día, según gravedad del proceso en curso, por vía oral, en 154 pacientes con afecciones respiratorias, otorrinolangológicas, cutáneas y urinarias...